As it happens, Bruker issued 9.5% more new shares over the last year. That means its earnings are split among a greater number of shares. Per share metrics like EPS help us understand how much ...

The test is expected to make the diagnosis of prostate cancer easier. Image credit: Jo Panuwat D via Shutterstock EDX Medical has developed a new non-invasive prostate cancer test it hopes will ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

Bruker (BRKR) reported $979.6 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 14.6%. EPS of $0.76 for the same period compares to $0.70 a year ago.

Bitcoin Cash (BCH) surged to a fresh one-year high on Monday, more than doubling in value in the week since it was listed on EDX Markets, a crypto exchange backed by Fidelity Digital Assets ...

For more information about these options, see the Getting Help page. The Open edX Code of Conduct All community members are expected to follow the Open edX Code of Conduct.